TS
Tejaswini Shahadev Patil
About Tejaswini Shahadev Patil
Data last updated:
Tejaswini Shahadev Patil has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Shri Swami Samarth Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Shri Swami Samarth Pharmaceuticals Limited at ₹2.49 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Shri Swami Samarth Pharmaceuticals Limited U24230MH2004PLC149048 | Director | 05 Apr 2022 | 2004 | ₹2.49 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Tejaswini Shahadev Patil
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tejaswini Shahadev Patil
Tejaswini Shahadev Patil has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Shri Swami Samarth Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Shri Swami Samarth Pharmaceuticals Limited at ₹2.49 Cr (FY 2025).
Tejaswini Shahadev Patil is associated with 1 company as Director, including Shri Swami Samarth Pharmaceuticals Limited (₹2.49 Cr).
Tejaswini Shahadev Patil has expertise in General Business.
Tejaswini Shahadev Patil has 4 years in corporate governance.
By reported revenue, the largest current company of Tejaswini Shahadev Patil is Shri Swami Samarth Pharmaceuticals Limited, with revenue of ₹2.49 Cr (FY 2025).
Tejaswini Shahadev Patil currently holds positions at 1 company: Shri Swami Samarth Pharmaceuticals Limited (₹2.49 Cr).